Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,835.70 INR | +0.60% |
|
-0.87% | -14.18% |
Chart calendar Alkem Laboratories Limited
b22818fd96888f37c.EHfjz8ELPJMi_4NfFh2_gs2bs1pwspd7b8loqDyhhl4.ZTuV-Zl-f8Ful9sKYW_zwanyhyovn68OAoAr70vxvzp8Bqr3qjNRwhTKsw~6a9cdf0ab3bba4bbdb1e0a76489d49f6
Upcoming events on Alkem Laboratories Limited
Past events on Alkem Laboratories Limited
Past dividends on Alkem Laboratories Limited
2025-02-13 | Interim Payment 37 INR |
2024-08-08 | Final Payment 5 INR |
2024-02-15 | Interim Payment 35 INR |
2023-08-09 | Final Payment 10 INR |
2023-02-16 | Bonus Payment 25 INR |
2023-02-16 | Interim Payment 15 INR |
2022-08-07 | Final Payment 4 INR |
2022-02-09 | Interim Payment 30 INR |
2021-08-08 | Final Payment 5 INR |
2021-02-10 | Interim Payment 25 INR |
2020-08-09 | Final Payment 3 INR |
2020-02-12 | Interim Payment 22 INR |
2019-08-18 | Final Payment 8 INR |
2019-02-14 | Interim Payment 8 INR |
2018-08-22 | Final Payment 7 INR |
2018-02-15 | Interim Payment 6 INR |
2017-08-30 | Final Payment 9 INR |
2016-11-22 | Interim Payment 6 INR |
2016-03-17 | Interim Payment 9.7 INR |
Annual results
Fiscal Period | March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 106 342 105 246 1.04% | 115 993 114 710 1.12% | 126 676 129 165 -1.93% | 129 645 130 615 -0.74% | 141 424 | 155 499 |
EBITDA Million INR | Released Forecast Spread | 20 529 21 156 -2.96% | 16 095 17 275 -6.84% | 22 455 22 807 -1.55% | 25 122 25 595 -1.85% | 28 013 | 32 144 |
EBIT Million INR | Released Forecast Spread | 17 490 18 315 -4.51% | 12 990 14 172 -8.34% | 19 462 19 851 -1.96% | 21 550 22 269 -3.23% | 24 027 | 27 662 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 18 443 19 610 -5.95% | 13 048 14 970 -12.84% | 20 231 21 419 -5.54% | 25 270 25 162 0.43% | 27 806 | 32 302 |
Net income Million INR | Released Forecast Spread | 16 456 18 079 -8.98% | 9 842 12 628 -22.07% | 17 958 18 687 -3.9% | 21 655 21 906 -1.15% | 23 370 | 22 646 |
EPS INR | Released Forecast Spread | 138 150 -8.37% | 82,3 106 -22.07% | 150 153 -1.91% | 181 185 -1.87% | 196 | 192 |
Announcement Date | 13/05/22 | 19/05/23 | 29/05/24 | 29/05/25 |
Quarterly results
Fiscal Period | March | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 30 794 30 137 2.18% | 30 409 29 535 2.96% | 29 026 27 604 5.15% | 29 677 28 288 4.91% | 34 402 33 575 2.46% | 33 239 32 679 1.71% | 29 358 31 959 -8.14% | 30 318 31 749 -4.51% | 36 087 | 34 901 | 31 681 | 32 304 | 37 045 | 36 335 | 34 387 |
EBITDA Million INR | Released Forecast Spread | 4 539 5 213 -12.92% | 5 991 4 845 23.65% | 3 533 4 462 -20.83% | 3 892 3 614 7.68% | 7 467 5 371 39.04% | 7 076 6 025 17.44% | 4 020 4 634 -13.25% | 6 086 5 089 19.6% | 7 913 | 7 161 | 4 569 | 6 271 | 8 120 | 7 813 | 6 006 |
EBIT Million INR | Released Forecast Spread | 3 765 4 530 -16.88% | 5 206 4 147 25.55% | 2 749 3 688 -25.44% | 3 168 2 956 7.17% | 6 728 4 722 42.49% | 6 380 5 200 22.7% | 3 186 4 496 -29.15% | 5 282 4 386 20.43% | 7 235 | 6 385 | 3 809 | 4 860 | 7 171 | 6 878 | 5 121 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 4 023 4 790 -16% | 5 389 4 343 24.1% | 2 117 3 912 -45.89% | 3 529 3 296 7.05% | 6 480 4 800 35.02% | 6 549 5 500 19.07% | 3 673 4 596 -20.07% | 6 194 4 600 34.64% | 7 600 | 6 625 | 4 316 | 5 916 | 8 232 | 7 850 | 6 140 |
Net income Million INR | Released Forecast Spread | 3 308 4 087 -19.06% | 4 547 3 672 23.84% | 710 3 322 -78.63% | 2 867 2 665 7.61% | 6 205 4 005 54.92% | 5 950 4 711 26.3% | 2 936 3 682 -20.27% | 5 452 4 023 35.52% | 6 699 | 6 156 | 3 725 | 5 208 | 6 984 | 6 594 | 5 115 |
EPS INR | Released Forecast Spread | 27,7 34,8 -20.51% | 38,0 29,4 29.22% | 51,9 28,5 82.11% | 24,6 34,0 -27.79% | 45,6 36,0 26.67% | 56,0 | 50,6 | 30,0 | 43,9 | 59,7 | 56,2 | 44,8 | |||
Announcement Date | 11/11/22 | 10/02/23 | 19/05/23 | 10/08/23 | 07/11/23 | 09/02/24 | 29/05/24 | 09/08/24 | - | - | - | - | - | - | - |
2025-07-15 | GLAND PHARMA LIMITED: Q1 2026 Earnings Release (Projected) |
2025-07-16 06:45 am | JOHNSON & JOHNSON: Q2 2025 Earnings Release |
2025-07-16 | NOVARTIS AG: Q2 2025 Earnings Release |
2025-07-17 01:00 am | CAMURUS AB: Q2 2025 Earnings Release |
2025-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2026 Earnings Release (Projected) |
2025-07-18 05:00 am | ORION OYJ: Q2 2025 Earnings Release |
2025-07-22 | DR. REDDY'S LABORATORIES LIMITED: Q1 2026 Earnings Release |
2025-07-22 | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Q2 2025 Earnings Release (Projected) |
2025-07-22 | GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.: Q2 2025 Earnings Release |
2025-07-23 01:00 am | COSMO PHARMACEUTICALS N.V.: Q2 2025 Earnings Release |
Past sector events for Alkem Laboratories Limited
2025-07-10 04:22 am | LOTUS PHARMACEUTICAL CO., LTD.: June 2025 Sales and Revenue Release |
2025-07-09 07:51 pm | BORA PHARMACEUTICALS CO., LTD.: June 2025 Sales and Revenue Release |
2025-07-09 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
2025-07-09 04:26 am | YUNGSHIN GLOBAL HOLDING CORPORATION: June 2025 Sales and Revenue Release |
2025-07-09 04:06 am | CALIWAY BIOPHARMACEUTICALS CO., LTD.: June 2025 Sales and Revenue Release |
2025-07-09 01:58 am | SYNMOSA BIOPHARMA CORPORATION: June 2025 Sales and Revenue Release |
2025-07-02 04:08 am | ONENESS BIOTECH CO., LTD.: June 2025 Sales and Revenue Release |
2025-06-17 11:45 am | MEDINCELL S.A.: Q4 2025 Earnings Release |
2025-06-10 04:38 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2025 Sales and Revenue Release |
2025-06-10 01:42 am | CENTER LABORATORIES, INC.: May 2025 Sales and Revenue Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALKEM Stock
- Calendar Alkem Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions